AAPM: Benzodiazepine Rx Increasing in Primary CareLast Updated: March 10, 2014. Benzodiazepines are increasingly prescribed in primary care, frequently with opioids, according to research presented at the annual meeting of the American Academy of Pain Medicine, held from March 6 to 9 in Phoenix.
MONDAY, March 10, 2014 (HealthDay News) -- Benzodiazepines are increasingly prescribed in primary care, frequently with opioids, according to research presented at the annual meeting of the American Academy of Pain Medicine, held from March 6 to 9 in Phoenix.
Sean Mackey, M.D., from the Stanford Systems Neuroscience and Pain Lab in Palo Alto, Calif., and colleagues examined trends in benzodiazepine prescriptions in primary care. Data were included from the National Ambulatory Medical Center Survey for 3.1 billion primary care visits between 2002 and 2009.
The researchers found that 12.6 percent of primary care visits involved prescriptions for benzodiazepines or opioids. There was a 12.5 percent increase seen in the prescriptions of benzodiazepines each year. Patient visits involving an opioid prescription were 4.2-fold more likely to also have simultaneous benzodiazepine prescriptions, after adjustment for patient demographics, including race, ethnicity, gender, and insurance status. There was a 12 percent increase in joint prescriptions of both benzodiazepines and opioids.
"More research is needed to elucidate the reason behind the increase in benzodiazepine prescription, and a national effort is needed to highlight the danger of co-prescription of benzodiazepines and opioids," Mackey said in a statement.
|Previous: AAPM: Post-Op Pain Highly Influential in Patient Satisfaction||Next: Marijuana Use Up, Cocaine Use Down, U.S. Report Finds|
Reader comments on this article are listed below. Review our comments policy.